Cowan, Robert
Cohen, Joshua M.
Rosenman, Erik
Iyer, Ravi
Funding for this research was provided by:
Teva Pharmaceutical Industries
Article History
Received: 14 February 2019
Accepted: 16 April 2019
First Online: 9 May 2019
Ethics approval and consent to participate
: This project (number 120180107) was approved by the New England Independent Review Board, LLC.
: Not applicable.
: R C: Served as a paid consultant to Teva on this project and was the sole.author of a white paper on which this work was based. He has also been a paid.consultant/advisor for Alder, Amgen, Allergan, Biohaven, and Lilly.J M. C: Employee of Teva Pharmaceuticals.E R: Employee of Healthcare Strategy Partners.R I: Employee of Teva Pharmaceuticals.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.